Summary by Futu AI
Adial Pharmaceuticals, Inc. (ADIL) has reported a transaction involving Anderson J. Kermit, a reporting person associated with the company. The transaction took place on March 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to await further information to fully assess the impact of this event on their investment decisions.